Literature DB >> 27086249

Obtaining employment as an anchor for estimating the minimum clinically important difference on the Positive and Negative Syndrome Scale (PANSS) in schizophrenia.

Meaghan A Leddy-Stacy1, Robert Rosenheck2.   

Abstract

Statistical differences on clinical scales are often used to compare the effectiveness of treatments. However, statistical significance does not necessarily indicate clinical significance. The minimum clinically important difference (MCID) refers to clinically meaningful treatment differences. This study estimates the MCID of the Positive and Negative Syndrome Scale (PANSS) by anchoring the change in scores to an objective clinical outcome: employment. This secondary analysis compared PANSS score change from baseline among 1049 non-working individuals with schizophrenia, who were followed and categorized as either having not worked, worked 1-10 days, or worked >10 days at 15 or 18 months. The difference in change in average PANSS Total scores between participants who did not work and those who worked 1-10 days (4.25 points) and >10 days (8.30) were statistically significant. This study estimates the MCID for the PANSS to be between 4.25 and 8.30 Total points. This study revealed significant differences in PANSS score changes between participants who did and did not work. Using employment, an objective and clinically meaningful change in health status, to determine the MCID of PANSS resulted in estimates lower than previously reported. MCID estimates vary across methods but using objective anchors increases face validity. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Clinical trials as topic; Employment; Psychiatric status rating scales; Research design; Schizophrenia; Treatment outcome

Mesh:

Substances:

Year:  2016        PMID: 27086249     DOI: 10.1016/j.psychres.2016.02.018

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  4 in total

1.  Minimal Clinically Important Differences (MCID) in Assessing Outcomes of Post-Traumatic Stress Disorder.

Authors:  Elina A Stefanovics; Robert A Rosenheck; Karen M Jones; Grant Huang; John H Krystal
Journal:  Psychiatr Q       Date:  2018-03

Review 2.  Humour-based interventions for people with schizophrenia.

Authors:  Yasushi Tsujimoto; Yuri Nakamura; Masahiro Banno; Kunihiro Kohmura; Hiraku Tsujimoto; Yuki Kataoka
Journal:  Cochrane Database Syst Rev       Date:  2021-10-13

3.  Methodological challenges in indirect treatment comparisons: spotlight on a recent comparison of long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia.

Authors:  Arun Singh; Srihari Gopal; Edward Kim; Maju Mathews; Jennifer Kern-Sliwa; Ibrahim Turkoz; Annette Wooller; Jesse Berlin
Journal:  Int Clin Psychopharmacol       Date:  2018-07       Impact factor: 1.659

4.  Schizophrenia and work: aspects related to job acquisition in a follow-up study.

Authors:  Larissa C Martini; Jair B Barbosa Neto; Beatriz Petreche; Ana O Fonseca; Fernanda V Dos Santos; Lílian Magalhães; Alessandra G Marques; Camila Soares; Quirino Cordeiro; Cecília Attux; Rodrigo A Bressan
Journal:  Braz J Psychiatry       Date:  2017-08-21       Impact factor: 2.697

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.